Atherosclerosis and associated diseases Flashcards

1
Q

Distinguish arteriosclerosis and atherosclerosis

A

Arteriosclerosis - narrowing/hardening of arteries as result of aging: prolif. of SMC, loss of elasticity, intimal fibrosis

Atherosclerosis - narrowing of arteries as result of formation of atheromatous plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline stages of atheroma development

A
  1. Fatty streak in intima- lipid laden macrophages/foamy cells, no clinical sig.
  2. Early plaque - round smooth plaque in intima formed by foamy cells
  3. Fully developed plaque - large, confluent plaques. May be calcified. Features:
    - lipid core: dead macros, crystallised lipid
    - Foamy cell rim around core: soft and highly thrombo
    - Fibrous cap - consists of SMC’s proliferated from epithelium, collagen and inflammatory cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Features of complicated plaque

A

Haemorrhage into plaque - causes swelling, narrowing of artery
Fissuring of plaque and thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the 2 biggest risk factors for atherosclerosis

A

Hypercholesterolaemia - mutation causing decrease in LDL receptors, heterozygous = major risk factor, cholesterol >8mmol. Homozygous = extreme risk, ultra high LDL cholesterol, death in infancy/childhood from atherosclerosis

Hyperlipidaemia - inherited or secondary. Causes elevated LDL/HDL/Total

Investigation: biochemistry, corneal arcus, tendon xanthomata, xanthalesma - fatty lumps around eyes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List other major risk factors for atherosclerosis

A

Hypertension, Smoking, Diabetes, Poor diet, Male, Age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lesser risk factors

A

Obesity, lack of exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the role of hypercholesterolaemia in plaque development

A

responsible for injury, hypercholesterolaemia causes pro-inflammatory state and productino of ROs.

ROs react with cholesterol that accumulates in intima, forming lipoproteins that cannot be digested by Macros. These cause foamy cell formation and death in plaques.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline development of atheromatous plaque

A

initial injury - turbulent flow or result of hypercholesterolaemia.

injury causes expression of ICAMs and VCAMs which adhere to monocytes and platelets.

Platelets cause clotting above injury.
Mono’s diff. become macros, phag. lipids and become foamy cells., accumulate in injury forming streak/early plaque.

inflammatory response to injury - platelets release PDGF
foamy macros are toxic to epithelial cells, release cytokines and growth factors.

Migration of SMC’s and T cells into intima. Proliferation of SMC’s and production of ECM - collagen, elastin.

Formation of fibrous cap.

Plaque maintained in pro-inflamm. state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe micro-thrombi

A

small thrombi that form on denuded areas of plaque by same mechanisms as plaque.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Complications of non-complicated atheromatous plaques

A

angina on exertion - 50-70% stenosis
angina at rest - >70%
Intermittent claudication if stenosis in lower limb arteries
Thrombus formation.
Atrophy of distal organs due to long term ischemia eg. kidneys in renal artery stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Disease resulting from complicated plaque

A

Thrombus formation causing MI, irreversible ischaemia.
Aortic rupture
thrombo-embolism,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which plaques are most vulnerable to rupture

A

thin walled, highly inflammed, large lipid core

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List possible damage caused by irreversible ischamia

A

MI
massive stroke (carotid/cerebral)
Gangrene/tissue necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List possible effects of Thrombo-embolism

A

Stroke, infarcs in distant tissues, MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

outline aortic rupture as result of stenosis

A

thinning of aorta wall due to inflamm. eventual rupture, massive peritoneal bleed, likely death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Outline treatment of angina

A

Treat symptoms - CCB and B blocker to reduce contractility and cardiac demand. GTN for vasodilation and ivabridine.

Treat underlying causes - HT, hyperlipidemia

Prevention of disease - ACEI to prevent further vascular damage. Statin to lower lipid.

Antiplatelets - aspirin, clopidegrol

17
Q

treatment of NSTEMI

A

For symptoms - MONA - morphine, O2, Nitrates, Aspirin/Clopidegrol

  • then: Beta blocker, LMWH.

Subsequent management:

  • ACEi and long term beta blocker to reduce heart O2 demand
  • Anti platelet to prevent subsequent thrombosis
  • Statin to reduce lipid levels

Advise changes in lifestyle!

18
Q

treatment of STEMI

A

Symptoms: MOA - Morphine, Oxygen, antiplatelet (aspirin+clopidegrol)

Then PCI + anti-platelet if immediately available, or thrombolysis and transfer for subsequent PCI if required.

Subsequent management:

  • ACEi and long term beta blocker to reduce heart O2 demand
  • Anti platelet to prevent subsequent thrombosis
  • Statin to reduce lipid levels

Advise changes in lifestyle!

19
Q

Treatment of Heart failure

A

Diuretic - Furosemide + TLD

ACE Inhibitor or Angiotensin receptor blocker

Beta blocker - Bisoprolol
– or if intolerant Ivabradine – inhibits signaling from SA

Digoxin
Warfarin

20
Q

Treatment of stroke

A

Establish whether ischemic or haemorrhagic

Ischemic:

Thrombolyse if within 4.5 hours + Antiplatelet - (aspirin/clopidegrol)
Manual clot retrieval if ultra dense clot + thrombolysis

hemicraniotomy may be required if massive cerebral oedema.

subsequent management: antiplatelet and warfarin/ribaroxiban for 3 months

Treatment of underlying risk factors.

21
Q

Treatment of claudication, critical limb ischemia and acute critical limb ischemia

A

Preventative - underlying factors
Anti-thrombotics: LMWH, clopidegrol
ACEi for HT
Statin to lower cholesterol

curative - PTA

For acute critical limb ischemia:

Thrombolysis and angioplasty or embolectomy.
Amputation may be required if tissue is necrotic

22
Q

Describe treatment for DVT, PE and massive PE

A

DVT and PE: LMWH (deltaparin, fondiparinux) until INR is >2, then warfarin

Massive PE - Thrombolysis or surgical embolectomy. then LMWH (deltaparin, fondiparinux) until INR is >2, then warfarin

23
Q

Treatment of mitral stenosis

A

Diuretics to reduce preload and afterload

Reduce dietary Na

Surgical - ballooning/valvotomy or valve replacement in severe disease

24
Q

Treatment of mitral regurg

A

If acute - diuretic, possible GTN.

If chronic - valve replacement

If AF is present treat accordingly (Beta blocker, digoxin, anticoag.)

25
Q

Treatment of aortic stenosis

A

Always aim for surgical replacement/repair within 1 month

26
Q

Treatment of aortic regurgitation

A

replacement and repair

27
Q

Describe possible complications of surgery to repair/replace heart valves

A

Complications with sternotomy - pain, infection, lack of sternal union

Cardiac tamponade, MI, stroke, sudden cardiac death

Complications with replacement valves - requirement for anticoag for prosthetic, biological wear out within 15 years.

28
Q

Treatment of chronic AF

A

Differing treatment if controlling rate or rhythm is the issue:

Rate - Beta blocker or CCB (NOT BOTH can cause heart failure) possible digoxin

Rhythm - Cardioversion - D/C electrical or pharmacologica (Amiodarone/flecainide)

Anticoagulation for both based on CHADS score

Possible use of pacemaker in drug resistant tachycardias

29
Q

Treatment of acute AF

A

Cardioversion - D/C or pharma

30
Q

Treatment of ventricular tachycardia and fibrillation

A

tachycardia - Beta blocker + cardioversion or Adenosine

Fibrillation - Cardioversion

31
Q

Treatment of heart block

A

First degree heart block may not require any treatment. 2nd and 3rd usually require a pacemaker

32
Q

Treatment of Hypertrophic cardiomyopathy

A

Prevent risk of developing tachycardia/fibrillation - Beta blocker

Surgical resection of tissue

33
Q

Treatment of dilated cardiomyopathy

A

diuretics

anti-thrombotic use for prophylaxis against thrombus formation

treatment of AF if present

treatment of anaemia if present.

34
Q

Treatment of infective endocarditis

A

Bacterial: If native/biological valve - gentamicin+amoxicillin or vancomycin. If prosthetic rifampicin

Fungal - dual antifungal eg. azole and polyene.

Valve replacement is required if infection is resistant or valve is perforated.